• london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share
Notification
  • london biotech banner
  • Dermatology June 24 Conference
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
Have an existing account? Sign In
MedEdge MEA > Health For All > Women and Child Health > New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Women and Child Health

New Hope for Malaria Control: Mozambique Introduces R21 Vaccine

ME Web Desk
Web Desk
Published: August 8, 2024
Share
3 Min Read
Hope for Malaria Control: Mozambique Introduces R21 Vaccine
SHARE

Maputo- August 2024- Mozambique reached an important milestone in malaria prevention among children with the introduction of the R21 vaccine, which will help reduce malaria cases and save thousands of children’s lives each year. In Africa, one child dies from malaria every minute.

Through Gavi, the Vaccine Alliance, and co-financing from the Government of Mozambique, the country has received about 800 000 malaria vaccine doses to vaccinate around 300 000 children through the country’s Expanded Programme on Immunization. The vaccine will cover 22 districts in Zambézia province. Children aged 6 to 11 months will receive the first dose in a 4-dose schedule.

“The malaria vaccine, which is being rolled out initially in Zambezia today, is one of the latest approaches in the fight against the disease,” said Hon Dr Armindo Tiago, Minister of Health. “The choice of Zambezia as the launch site is due to the high burden of the disease in the province. The vaccine will be administered in four doses with the aim of reducing the severe malaria illness and death.”

The WHO-recommended R21 vaccine is safe and effective. When provided in childhood immunization (programme?), it reduces over half of malaria cases (as high as 66%) in children during the first year of follow-up and prolonged protection with the fourth dose of vaccine. Moreover, This vaccine represents an advancement for child health, disease control and reduction of child mortality. In Mozambique, malaria endemic, with a prevalence of 32% in under 5 children.

Also Read: Know This: Back-to-School event focuses on Asthma education

“The introduction of the malaria vaccine into Mozambique’s childhood vaccination programme is a historic event because it is the result of research and trials carried out by Mozambican scientists in Mozambique that led to the development of the first vaccine of its kind, the RTS,S vaccine. This pioneering work laid the foundations for WHO to recommend the RTS,S and R21 vaccines for childhood immunization from 2021,” Dr Severin von Xylander, WHO Representative in Mozambique

Gavi, UNICEF, WHO and other partners are supporting the Ministry of Health in the preparation, acceptance and introduction of the malaria vaccine. The support ranges from developing vaccine implementation plans, communication strategies, conducting health professional training and community engagement, and ensuring sufficient cold chain capacity.

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Sysmex and QIAGEN Strengthen Partnership for Genetic Testing Sysmex and QIAGEN Strengthen Partnership to Advance Genetic Testing
Next Article Imperial College AHSC Names Mark Thursz as New Director Imperial College AHSC Names Mark Thursz as New Director

Recent Posts

  • WCM-Q Earns Global Recognition as Diabetes Center of Excellence by IDF
  • AbbVie and ADARx Announce $335 Million Collaboration to Develop Cutting-Edge RNA Therapeutics
  • NATIONAL MS SOCIETY ANNOUNCES 2025 RESEARCH GRANT AWARDEES
  • Japan to Begin Clinical Trials for Artificial Blood in 2025
  • Future Trends in RegTech : How AI is Transforming Regulatory Authorities and Processes
  • Dermatology expo rome
  • LifeSpin
Two Point Five Logo white
  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share

Published by Two Point Five Media FZCO

  • About Us
  • Terms and Conditions
  • Privacy Policy
  • Submit Your Story
  • Contact Us
  • MediaKit
Reading: New Hope for Malaria Control: Mozambique Introduces R21 Vaccine
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?